Latest AI and machine learning research in breast cancer for healthcare professionals.
BACKGROUND: Muscle-invasive bladder cancer (MIBC) is an aggressive and heterogeneous malignancy with limited biomarkers to guide patient stratification and response to neoadjuvant chemotherapy (NAC). We sought to define the biological basis and clinical utility of a bladder cancer-associated ten-gene signature for predicting prognosis and therapeutic response. METHODS: Bulk transcriptomic data fro...
Neoadjuvant therapy (NAT) has strengthened systemic control in breast cancer and promoted precision de-escalation of axillary management. For clinically node-negative patients, evidence supports sentinel lymph node biopsy (SLNB) after NAT; among human epidermal growth factor receptor 2(HER2)-positive and triple-negative breast cancer patients achieving breast pathological complete response, the ri...
Multi-omics data integration holds great promise for precision medicine, yet its clinical adoption is hindered by high acquisition costs and the compl...
INTRODUCTION AND AIMS: Periapical radiography is widely used in dental practice, but its diagnostic yield is often compromised by motion artefacts, se...
BACKGROUND: Cardiovascular disease (CVD) is a major concern among cancer survivors. However, the intersection of cancer and CVD has only recently gain...
BACKGROUND: Brain metastases (BM) are the most common intracranial tumors in adults, and stereotactic radiosurgery (SRS) has become a mainstay of mana...
PURPOSE: To evaluate the dosimetric benefit of deep inspiration breath-hold (DIBH) using the Active Breathing Coordinator (ABC) for left-sided breast ...
BACKGROUND: Cervical cancer (CC) ranks among the most prevalent malignant neoplasms affecting women worldwide. Tumor recurrence, distant metastases, a...
Manganese metabolism may be involved in the malignant progression of lung adenocarcinoma (LUAD). Clarifying the roles of manganese metabolism-related ...
Exosomes play a key role in cancer, functioning both as drivers of drug resistance and as tools for therapy. Tumor-derived exosomes facilitate interce...
INTRODUCTION: Pathological complete response (pCR) is a key prognostic indicator in breast cancer (BC) patients receiving neoadjuvant chemotherapy (NA...
Ki-67 is a well-established marker of tumour proliferation and an important prognostic and predictive biomarker in breast cancer, particularly in horm...
Tumor recurrence represents a significant challenge in the field of tumor therapy, severely affecting patients' survival rates and quality of life. Ev...
OBJECTIVES: This study aimed to develop and validate a clinically motivated artificial intelligence framework for preoperative risk assessment of the ...
Triple-negative breast cancer (TNBC), being one of the most aggressive subtypes of breast malignancies, is characterized by poor prognosis and limited...
BACKGROUND: Radiation-induced erectile dysfunction (RIED) remains one of the most prevalent and distressing late toxicities among prostate cancer surv...
RATIONALE AND OBJECTIVES: Although accurate preoperative prediction of sentinel lymph node (SLN) status in operable early-stage breast cancer (EBC) af...
PURPOSE OF REVIEW: Advanced gynecologic cancers are treated broadly, with variable outcomes, even when selected by traditional precision oncology biom...
A mechanistic understanding of how genetic variants alter drug-receptor binding is central to precision medicine, drug response prediction, and drug d...
BACKGROUND: The Phoenix definition is widely used to define biochemical recurrence (BCR) after radiation therapy for prostate cancer; however, a defin...